🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the immunogenicity and safety of GlaxoSm...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-24
Trial ID
NCT00996125
Treatments Being Tested
The main objective of this study is to develop protocols using FV urine tha...
Status
Completed
Location
Universiteit Antwerpen
Start Date
2020-05-11
Trial ID
NCT04391647
Treatments Being Tested
Cervical cancer is the second most common cancer among women worldwide. App...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-01
Trial ID
NCT00481767
Treatments Being Tested
This extension study is designed to assess the safety of GSK Biological's h...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-01
Trial ID
NCT01190189
Treatments Being Tested
The study aims to identify global and local determinants of HPV vaccine acc...
Status
Completed
Location
Chu Reims
Start Date
2016-05
Trial ID
NCT02837926
Treatments Being Tested
This study is to evaluate lot-lot consistency of Recombinant Human Papillom...
Status
Completed
Location
Dongtai City Center for Disease Control and Prevention Dongtai, Jiangsu
Start Date
2020-05-01
Trial ID
NCT05426148
This is a multicenter study in which women are planned to receive either th...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-10-22
Trial ID
NCT00779766
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-26
Trial ID
NCT01031069
Cervical cancer is the most common cancer in women aged 15-44 years in East...
Status
Active Not Recruiting
Location
Mwanza Intervention Trials Unit (MITU)
Start Date
2017-02-23
Trial ID
NCT02834637
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-22
Trial ID
NCT00947115
Treatments Being Tested